Cardiovascular potential of BM-derived stem and progenitor cells

References

• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–5.
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–7.
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic revascularization. Proc Natl Acad Sci USA 2000;97:3422–7.
   PubMed Web of Science ®Google Scholar
• Chein KR. Lost in translation. Nature 2004;428:607–8.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913–8.
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C et al. Transplantation of progenitor cells ands regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009–17.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004;364:141–8.
   PubMed Web of Science ®Google Scholar
• Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45–6.
   PubMed Web of Science ®Google Scholar
• Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mono-nuclear cell implantation. Lancet 2003;361:47–9.
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HFR, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;108:361:2294–302.
   Google Scholar
• Fuchs S, Satler LF, Kornowski R et al. Catheter-based auto-logous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. 7Am Coll Cardiol 2003;41: 1721–4.
   Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T et al. Ther-apeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427–35.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kimura M, Hara K et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-depen-dent vasodilation in patients with limb ischemia. Circulation 2004;109:1215–8.
   PubMed Web of Science ®Google Scholar
• Deb A, Wang S, Skelding KA et al. Bone marrow-derived cardiomyocytes are present in adult human heart. A study of gender-mismatched bone marrow transplantation patients. Cir-culation 2003;107:1247–9.
   Google Scholar
• Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2and AC133 by circulating CD34± cells identifies a population of functional endothelial precursors. Blood 2000;95:952–8.
   PubMed Web of Science ®Google Scholar
• Gehling UM, Ergun S, Schumacher U et al. In vitro differentia-tion of endothelial cells from AC133-positive cells. Blood 2000;95:3106–12.
   PubMed Web of Science ®Google Scholar
• Ito JM, Rovira II, Bloom ML et al. Endothelial progenitor cellsas putative targets for angiostatin. Cancer Res 1999;59:5875–7.
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. 7 Clin Invest 2000;105:1–7.
   Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A et al. Number and migratoryactivity of circulating endothelial cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:1–7.
   PubMed Web of Science ®Google Scholar
• Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164–9.
   PubMed Web of Science ®Google Scholar
• Urbich C, Heeschen C, Aicher A et al. Relevance of monocyticfeatures for neovascularization capacity of circulating endothe-lial progenitor cells. Circulation 2003;108:2511–6.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434–8.
   PubMed Web of Science ®Google Scholar
• Gill M, Dias S, Hattori K et al. Vascular trauma induces rapid but transient mobilization of VEGFR( )ACC133( ) endothe-lial precursor cells. Circ Res 2001;88:167–74.
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl 7 Med 2003;348:593–600.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. 7 Clin Invest 2001;108: 391–7.
   Google Scholar
• Llevadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductaseinhibitor mobilizes bone marrow-derived endothelial progenitor cells. 7 Clin Invest 2001;108: 399–405.
   Google Scholar
• Melino G, Bernassola F, Knight RA et al. S-nitrosylation regulates apoptosis. Nature 1997;388:432–3.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885–90.
   PubMed Web of Science ®Google Scholar
• Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109:220–6.
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role ofendothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370–6.
   PubMed Web of Science ®Google Scholar
• Gu Z, Kaul M, Yan B et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002;297:1186–90.
   PubMed Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625— 37.
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajsrura J, Chimenti S et al. Mobilized bone marrowcells repair the infarcted heart improving function and survival. Proc Nati Acad Sci USA 2001;98:10344–9.
   PubMed Web of Science ®Google Scholar
• Seiler C, Pohl T, Wustmann K et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 200114:201–7.
   Google Scholar
• Kang H-J, Kim H-S, Zhang S-Y et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulo-cyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 2004;363:751 — 6.
   PubMed Web of Science ®Google Scholar